ID: ALA5288916
Chembl Id: CHEMBL5288916
Max Phase: Preclinical
Molecular Formula: C19H22N4S
Molecular Weight: 338.48
Associated Items:
Canonical SMILES: CC(C)CNc1ccnc(NCc2csc(-c3ccccc3)c2)n1
Standard InChI: InChI=1S/C19H22N4S/c1-14(2)11-21-18-8-9-20-19(23-18)22-12-15-10-17(24-13-15)16-6-4-3-5-7-16/h3-10,13-14H,11-12H2,1-2H3,(H2,20,21,22,23)
Standard InChI Key: SPBSZKORELYQFI-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 338.48 | Molecular Weight (Monoisotopic): 338.1565 | AlogP: 4.89 | #Rotatable Bonds: 7 |
| Polar Surface Area: 49.84 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 7.19 | CX LogP: 4.66 | CX LogD: 4.46 |
| Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.64 | Np Likeness Score: -1.31 |
| 1. Zhao W, Sun X, Shi L, Cai SZ, Ma ZR.. (2022) Discovery of novel analogs of KHS101 as transforming acidic coiled coil containing protein 3 (TACC3) inhibitors for the treatment of glioblastoma., 244 [PMID:36332551] [10.1016/j.ejmech.2022.114874] |
Source(1):
